COMMUNIQUÉS West-GlobeNewswire

Genesis to Present at the Barclays Global Healthcare Conference on March 12, 2019; Expects to Release Fourth Quarter and Year End 2018 Results on March 18, 2019
04/03/2019
KENNETT SQUARE, Pa., March 04, 2019 (GLOBE NEWSWIRE) -- Genesis HealthCare (NYSE:GEN) (Genesis or the Company), one of the nation’s largest providers of post-acute care, today announced that George V. Hager, Jr., Chief [...]
Proteon Therapeutics to Present at the Cowen and Company 39th Annual Health Care Conference on March 11th
04/03/2019
WALTHAM, Mass., March 04, 2019 (GLOBE NEWSWIRE) -- Proteon Therapeutics Inc. (Nasdaq: PRTO), a company developing novel, first-in-class therapeutics to address the medical needs of patients with kidney and vascular [...]
Flexion Therapeutics to Present at the Cowen 39th Annual Health Care Conference
04/03/2019
BURLINGTON, Mass., March 04, 2019 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) announced today that Michael Clayman, M.D., President and Chief Executive Officer, will present at the Cowen 39 th Annual [...]
Important New Data on Vascepa® (Icosapent Ethyl) from the REDUCE-IT™ Trial to Be Presented Regarding Reduction in Total Ischemic Events
04/03/2019
Multiple Scientific Presentations Scheduled for American College of Cardiology’s 68th Annual Scientific Session Amarin to Webcast Discussion of Presented Data March 18, 4:00-5:00 pm Central Time BEDMINSTER, N.J., and [...]
Dragon Jade Appoints Dr. Dominic Man-Kit Lam as Independent Director
04/03/2019
HONG KONG, March 04, 2019 (GLOBE NEWSWIRE) -- Dragon Jade International Limited (“Dragon Jade” or “the Company”) (OTCQX: DGJI), a provider of premier products and services, today announced the appointment of Dr. Dominic [...]
Otonomy Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Corporate Update
04/03/2019
OTIVIDEX™ Phase 3 trial in Ménière’s disease on track for results in first half 2020 OTO-313 Phase 1/2 trial in tinnitus expected to start in second quarter of 2019 OTO-413 Phase 1/2 trial in hearing loss expected to [...]
Kaleido Biosciences Announces Closing of Initial Public Offering
04/03/2019
LEXINGTON, Mass., March 04, 2019 (GLOBE NEWSWIRE) -- Kaleido Biosciences, Inc. (Nasdaq: KLDO), a clinical-stage healthcare company with a differentiated, chemistry-driven approach to leveraging the potential of the [...]
Inspire Medical Systems, Inc. Announces Five New Positive Coverage Policies Issued by Blue Cross Blue Shield Plans
04/03/2019
MINNEAPOLIS, March 04, 2019 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative and minimally invasive [...]
Vital Therapies Announces 2018 Financial Results
04/03/2019
SAN DIEGO, March 04, 2019 (GLOBE NEWSWIRE) -- Vital Therapies, Inc. (Nasdaq: VTL), a biotherapeutic company that has been developing ELAD®, a cell-based therapy targeting the treatment of acute forms of liver failure, [...]
Autolus Therapeutics to Present at the Cowen and Company 39th Annual Healthcare Conference
04/03/2019
LONDON, March 04, 2019 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (NASDAQ: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced that Dr. Christian [...]
OrthoPediatrics Corp. to Participate at The Canaccord Genuity 2019 Musculoskeletal Conference
04/03/2019
WARSAW, Ind., March 04, 2019 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (NASDAQ:KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, announced today that Mark Throdahl, President & [...]
Ascendis Pharma A/S Announces Proposed Public Offering of ADSs
04/03/2019
COPENHAGEN, Denmark, March 04, 2019 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq:ASND), a biopharmaceutical company that utilizes its innovative TransCon™ technology to address unmet medical needs, today announced [...]
Spring Bank to Host Conference Call to Discuss Fourth Quarter and Fiscal Year 2018 Results on Monday, March 11
04/03/2019
Conference Call to be Held at 8:00am Eastern Time HOPKINTON, Mass., March 04, 2019 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (Nasdaq: SBPH), a clinical-stage biopharmaceutical company developing novel [...]
La Jolla Pharmaceutical Company Announces Financial Results for the Three and Twelve Months Ended December 31, 2018 and Highlights Recent Corporate Progress and Key Objectives
04/03/2019
SAN DIEGO, March 04, 2019 (GLOBE NEWSWIRE) -- La Jolla Pharmaceutical Company (Nasdaq: LJPC), a leader in the discovery, development and commercialization of innovative therapies intended to significantly improve [...]
Apellis Pharmaceuticals to Present at the Cowen 39th Annual Health Care Conference
04/03/2019
WALTHAM Mass. and CRESTWOOD, Ky., March 04, 2019 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals Inc., (Nasdaq:APLS) a clinical-stage biopharmaceutical company focused on the development of novel therapeutic compounds to [...]
Les résultats décisifs de l'essai clinique de Phase 2 de Bermekimab dans le traitement de la dermatite atopique (AD) seront présentés le 2 mars 2019 au Congrès annuel de l'American Academy of Dermatology
04/03/2019
Réduction moyenne rapide et significative des lésions cutanées, réduction moyenne de 66 % (p < 0,001) et 76 % (p < 0,001) du score EASI, respectivement en 4 et 7 semaines. Résolution rapide et significative des [...]
Huddle handoff communication tool improves process of addressing workplace violence in health care
04/03/2019
Study appears in February 2019 issue of The Joint Commission Journal on Quality and Patient Safety OAKBROOK TERRACE, Ill., March 04, 2019 (GLOBE NEWSWIRE) -- Health care workplace violence is increasing in the United [...]
UPDATE -- Veritas Pharma to Commence Legal Proceedings Against Liht Cannabis
04/03/2019
VANCOUVER, British Columbia, March 04, 2019 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company”) announces that it has filed a claim and is commencing legal [...]
ContraVir Pharmaceuticals Announces Panel Participation at 31st Annual ROTH Conference
04/03/2019
– Investor Webinar Now Available on Company's Website – EDISON, N.J., March 04, 2019 (GLOBE NEWSWIRE) -- ContraVir Pharmaceuticals, Inc. (NASDAQ:CTRV), a biopharmaceutical company focused on the development and [...]

Pages